Cargando…
Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum
The use of 5-methylcytosine demethylating agents in conjunction with inhibitors of histone deacetylation may offer a new therapeutic strategy for lung cancer. Monitoring the efficacy of gene demethylating treatment directly within the tumour may be difficult due to tumour location. This study determ...
Autores principales: | Belinsky, S A, Grimes, M J, Casas, E, Stidley, C A, Franklin, W A, Bocklage, T J, Johnson, D H, Schiller, J H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360148/ https://www.ncbi.nlm.nih.gov/pubmed/17406356 http://dx.doi.org/10.1038/sj.bjc.6603721 |
Ejemplares similares
-
Gene methylation biomarkers in sputum as a classifier for lung cancer risk
por: Leng, Shuguang, et al.
Publicado: (2017) -
DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma
por: Seng, T J, et al.
Publicado: (2008) -
The relationship between aberrant methylation and survival in non-small-cell lung cancers
por: Toyooka, S, et al.
Publicado: (2004) -
Sequential gene promoter methylation during HPV-induced cervical carcinogenesis
por: Henken, F E, et al.
Publicado: (2007) -
Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancer
por: Xing, J, et al.
Publicado: (2008)